Determination of plasma and urine levels of Δ9-tetrahydrocannabinol and its main metabolite by liquid chromatography after solid-phase extraction

Journal of Pharmaceutical and Biomedical Analysis

Volumn 47, Issue 1, 2008, Pages 156-163

  Mercolini, Laura ^a   Musenga, Alessandro ^a   Comin, Irene ^a   Baccini, Cesare ^b   Conti, Matteo ^b   Raggi, Maria Augusta ^a  

^a Faculty of Pharmacy   (Italy)

^b SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

Author keywords

9 Tetrahydrocannabinol; 11 Nor 9 tetrahydrocannabinol 9 carboxylic acid; High performance liquid chromatography; Solid phase extraction; Therapeutic drug monitoring

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETONITRILE; AMITRIPTYLINE; AMPHETAMINE; BROTIZOLAM; BUPRENORPHINE; CITALOPRAM; CLOBAZAM; CLONAZEPAM; CODEINE; DIAZEPAM; DRONABINOL; FLUOXETINE; FLURAZEPAM; IMIPRAMINE; INDOMETACIN; LORAZEPAM; METHADONE; MIRTAZAPINE; MORPHINE; PHOSPHATE BUFFERED SALINE; SERTRALINE; TETRAHYDROCANNABINOLIC ACID; VENLAFAXINE;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG STRUCTURE; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; ULTRAVIOLET SPECTROSCOPY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; SOLID PHASE EXTRACTION; TETRAHYDROCANNABINOL;

EID: 41549119875     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.12.023     Document Type: Article

References (43)

1. Palmer S.L., Thakur G.A., and Makriyannis A. Chem. Phys. Lipids 121 (2002) 3-19
2. Crombie L. Pure Appl. Chem. 58 (1986) 693-700
3. Burns T.L., and Ineck J.R. Ann. Pharmacother. 40 (2006) 251-260
4. Heinrich M. Bioforum Eur. 9 (2005) 28-30
5. ® Product Monograph, 2006 (Retrieved on March 23, 2007, from http://www.bayerhealth.com/display.cfm?Object_ID=272&Article_ID=197).
6. Hazekamp A., Peltenburg A., and Verpoorte R. J. Liq. Chromatogr. R. T. 28 (2005) 2361-2382
7. Widman M., Agurell S., Ehrnebo M., and Jones G. J. Pharm. Pharmacol. 26 (1974) 914-916
8. Maurer H.H., Sauer C., and Theobald D.S. Ther. Drug Monit. 28 (2006) 447-453
9. Huestis M.A., Henningfield J.E., and Cone E.J. J. Anal. Toxicol. 16 (1992) 276-282
10. Gustafson R.A., Kim I., Stout P.R., Klette K.L., George M.P., Moolchan E.T., Levine B., and Huestis M.A. J. Anal. Toxicol. 28 (2004) 160-167
11. Johansson E., Halldin M.M., Agurell S., Hollister L., and Gillespie H.K. Eur. J. Clin. Pharmacol. 37 (1989) 273-277
12. Johansson E., and Halldin M.M. J. Anal. Toxicol. 13 (1989) 218-223
13. Naef M., Russmann S., Petersen-Felix S., and Brenneisen R. J. Pharm. Sci. 93 (2004) 1176-1184
14. Nahas G.G. Hum. Psychopharmacol. 16 (2001) 247-255
15. Giroud C., Ménétrey A., Augsburger M., Buclin T., Sanchez-Mazas P., and Mangin P. Forensic Sci. Int. 123 (2001) 159-164
16. Wall M.E., Sadler M.B., and Brine D. Clin. Pharmacol. Ther. 34 (1983) 352-363
17. Fraser A.D., and Worth D. J. Anal. Toxicol. 23 (1999) 531-534
18. Raharjo T.J., and Verpoorte R. Phytochem. Anal. 15 (2004) 79-94
19. Teixeira H., Proenca P., Verstraete A., Corte-Real F., and Vieira D.N. Forensic Sci. Int. 150 (2005) 205-211
20. Teixeira H., Verstraete A., Proenca P., Corte-Real F., Monsanto P., and Vieira D.N. Forensic Sci. Int. 170 (2007) 148-155
21. Kircher V., and Parlar H. J. Chromatogr. B 677 (1996) 245-255
22. Moore C., Guzaldo F., and Donahue T. J. Anal. Toxicol. 25 (2001) 555-558
23. Saito T., Wtsadik A., Scheidweiler K.B., Fortner N., Takeichi S., and Huestis M.A. Clin. Chem. 50 (2004) 2083-2090
24. Maralikova B., and Weinmann W. J. Chromatogr. B 811 (2004) 21-30
25. Maralikova B., and Weinmann W. J. Mass Spectrom. 39 (2004) 526-531
26. Weinmann W., Vogt S., Goerke R., Muller C., and Bromberger A. Forensic Sci. Int. 113 (2000) 381-387
27. Tai S.S.-C., and Welch M.J. J. Anal. Toxicol. 24 (2000) 385-389
28. Breindahl T., and Andreasen K. J. Chromatogr. B 732 (1999) 155-164
29. Paul B.D., and Jacobs A. J. Anal. Toxicol. 26 (2002) 460-463
30. Feng S., El-Sohly M.A., Salamone S., and Salem M. J. Anal. Toxicol. 24 (2000) 395-402
31. Backofen U., Hoffmann W., and Matysik F.-M. Biomed. Chromatogr. 14 (2000) 49-52
32. Krämer E., and Kovar K.-A. J. Chromatogr. B 731 (1999) 167-177
33. Parry R.C., Nolan L., Shirey R.E., Wachob G.D., and Gisch J.D. J. Anal. Toxicol. 14 (1990) 39-44
34. Ferrara S.D., Tedeschi L., Frison G., and Castagna F. J. Anal. Toxicol. 6 (1992) 217-222
35. Abbara C., Galy R., Benyamina A., Reynaud M., and Bonhomme-Faivre L. J. Pharmaceut. Biomed. 41 (2006) 1011-1016
36. Büchele B., Zugmaier W., and Simmet T. GIT Labor-Fachzeitschrift 48 (2004) 838-840
37. Bianchi V., and Donzelli G. J. Chromatogr. B 675 (1996) 162-167
38. Moore Christine C., Rana S., Coulter C., Day D., Vincent M., and Soares J. J. Anal. Toxicol. 31 (2007) 187-194
39. Crockett D.K., Nelson G., Dimson P., and Urry F.M. J. Anal. Toxicol. 24 (2000) 245-249
40. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., McGilveray I.J., Mckay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., and Yacobi A. Pharm. Res. 17 (2000) 1551-1557
41. United States Pharmacopeia, United States Pharmacopeial Convention, 28th ed., Rockville, 2005, pp. 2748-2751.
42. ICH Topic Q 2 B, Validation of analytical procedures: methodology, available from the site http://www.emea.europa.eu/pdfs/human/ich/028195en.pdf (Last accessed on 7 December 2007).
43. Roth K.D.W., Siegel N.A., Johnson Jr. R.W., Litauszki L., Salvati Jr. L., Harrington C.A., and Wray L.K. J. Anal. Toxicol. 20 (1996) 291-300